Literature DB >> 11785699

Molecular mobility and fragility in indomethacin: a thermally stimulated depolarization current study.

N T Correia1, J J Ramos, M Descamps, G Collins.   

Abstract

PURPOSE: To show that thermally stimulated depolarization currents (TSDC), which is a dielectric experimental technique relatively unknown in the pharmaceutical scientists community, is a powerful technique to study molecular mobility in pharmaceutical solids, below their glass transition temperature (Tg). Indomethacin (Tg = 42 degrees C) is used as a model compound.
METHODS: TSDC is used to isolate the individual modes of motion present in indomethacin, in the temperature range between -165 degrees C and +60 degrees C. From the experimental output of the TSDC experiments, the kinetic parameters associated with the different relaxational modes of motion were obtained, which allowed a detailed characterization of the distribution of relaxation times of the complex relaxations observed in indomethacin.
RESULTS: Two different relaxational processes were detected and characterized: the glass transition relaxation, or alpha-process, and a sub-Tg relaxation, or secondary process. The lower temperature secondary process presents a very low intensity, a very low activation energy, and a very low degree of cooperativity. The fragility index (Angell's scale) of indomethacin obtained from TSDC data is m = 64, which can be compared with other values reported in the literature and obtained from other experimental techniques.
CONCLUSIONS: TSDC data indicate that indomethacin is a relatively strong glass former (fragility similar to glycerol but lower than sorbitol, trehalose, and sucrose). The high-resolution power of the TSDC technique is illustrated by the fact that it detected and characterized the secondary relaxation in indomethacin, which was not possible by other techniques.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11785699     DOI: 10.1023/a:1013339017070

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  An investigation into the thermal behaviour of an amorphous drug using low frequency dielectric spectroscopy and modulated temperature differential scanning calorimetry.

Authors:  R He; D Q Craig
Journal:  J Pharm Pharmacol       Date:  2001-01       Impact factor: 3.765

Review 2.  The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems.

Authors:  D Q Craig; P G Royall; V L Kett; M L Hopton
Journal:  Int J Pharm       Date:  1999-03-15       Impact factor: 5.875

3.  The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity.

Authors:  V Andronis; G Zografi
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

Review 4.  Characteristics and significance of the amorphous state in pharmaceutical systems.

Authors:  B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1997-01       Impact factor: 3.534

5.  Molecular mobility of supercooled amorphous indomethacin, determined by dynamic mechanical analysis.

Authors:  V Andronis; G Zografi
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

6.  Entropy and Fragility in Supercooling Liquids.

Authors:  C A Angell
Journal:  J Res Natl Inst Stand Technol       Date:  1997 Mar-Apr
  6 in total
  15 in total

1.  The activation energy at Tg and the fragility index of indomethacin, predicted from the influence of the heating rate on the temperature position and on the intensity of thermally stimulated depolarization current peak.

Authors:  Joaquim J Moura Ramos; Natália T Correia; Raquel Taveira-Marques; George Collins
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

2.  Using thermally stimulated current (TSC) to investigate disorder in micronized drug substance produced at different milling energies.

Authors:  Rachel Forcino; Jeffrey Brum; Marc Galop; Yan Sun
Journal:  Pharm Res       Date:  2010-08-10       Impact factor: 4.200

3.  A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part II: molecular mobility and activation thermodynamic parameters.

Authors:  Rama A Shmeis; Zeren Wang; Steven L Krill
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

4.  Molecular mobility in raffinose in the crystalline pentahydrate form and in the amorphous anhydrous form.

Authors:  Joaquim J Moura Ramos; Susana S Pinto; Hermínio P Diogo
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

5.  Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.

Authors:  Chandan Bhugra; Rama Shmeis; Steven L Krill; Michael J Pikal
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

6.  Effect of sugars on the molecular motion of freeze-dried protein formulations reflected by NMR relaxation times.

Authors:  Sumie Yoshioka; Kelly M Forney; Yukio Aso; Michael J Pikal
Journal:  Pharm Res       Date:  2011-06-25       Impact factor: 4.200

7.  Probing beta relaxation in pharmaceutically relevant glasses by using DSC.

Authors:  Sergey Vyazovkin; Ion Dranca
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

8.  Mechanistic study of the solubilization effect of basic amino acids on a poorly water-soluble drug.

Authors:  Mohammed Suleiman Alsalhi; Paul G Royall; Ka Lung Andrew Chan
Journal:  RSC Adv       Date:  2022-06-29       Impact factor: 4.036

9.  Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.

Authors:  E Kaminska; K Adrjanowicz; D Zakowiecki; B Milanowski; M Tarnacka; L Hawelek; M Dulski; J Pilch; W Smolka; I Kaczmarczyk-Sedlak; K Kaminski
Journal:  Pharm Res       Date:  2014-05-15       Impact factor: 4.200

10.  Acoustic-like dynamics of amorphous drugs in the THz regime.

Authors:  E A A Pogna; C Rodríguez-Tinoco; M Krisch; J Rodríguez-Viejo; T Scopigno
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.